vs
Dianthus Therapeutics, Inc.（DNTH）与Sintx Technologies, Inc.（SINT）财务数据对比。点击上方公司名可切换其他公司
Sintx Technologies, Inc.的季度营收约是Dianthus Therapeutics, Inc.的1.0倍（$290.0K vs $284.0K），Sintx Technologies, Inc.净利率更高（-763.8% vs -22687.3%，领先21923.5%），Sintx Technologies, Inc.同比增速更快（-46.5% vs -78.6%），Sintx Technologies, Inc.自由现金流更多（$-2.4M vs $-47.1M），过去两年Sintx Technologies, Inc.的营收复合增速更高（-35.0% vs -44.6%）
Dianthus Therapeutics是一家临床阶段生物制药企业，专注开发罕见免疫与炎症疾病的新型靶向疗法，其抗体类候选管线聚焦解决重症患者未满足医疗需求，主要在北美开展临床研究与合作。
Sintx Technologies, Inc.是一家先进材料企业，专注于研发及生产高性能氮化硅与其他特种陶瓷产品，服务医疗植入部件、航空航天、国防、工业耐磨组件、电动汽车等核心领域，市场覆盖北美、欧洲及亚太地区。
DNTH vs SINT — 直观对比
营收规模更大
SINT
是对方的1.0倍
$284.0K
营收增速更快
SINT
高出32.1%
-78.6%
净利率更高
SINT
高出21923.5%
-22687.3%
自由现金流更多
SINT
多$44.7M
$-47.1M
两年增速更快
SINT
近两年复合增速
-44.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $284.0K | $290.0K |
| 净利润 | $-64.4M | $-2.2M |
| 毛利率 | — | 64.8% |
| 营业利润率 | -24486.3% | -799.3% |
| 净利率 | -22687.3% | -763.8% |
| 营收同比 | -78.6% | -46.5% |
| 净利润同比 | -126.6% | -30.7% |
| 每股收益（稀释后） | $-1.53 | $-0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DNTHSINT
| Q4 25 | $284.0K | $290.0K | ||
| Q3 25 | $396.0K | $208.0K | ||
| Q2 25 | — | $151.0K | ||
| Q1 25 | $1.2M | $369.0K | ||
| Q4 24 | $1.3M | $542.0K | ||
| Q3 24 | $2.2M | $799.0K | ||
| Q2 24 | $1.9M | $859.0K | ||
| Q1 24 | $874.0K | $687.0K |
净利润DNTHSINT
| Q4 25 | $-64.4M | $-2.2M | ||
| Q3 25 | $-36.8M | $-3.5M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | $-29.5M | $-2.3M | ||
| Q4 24 | $-28.4M | $-1.7M | ||
| Q3 24 | $-25.2M | $-6.2M | ||
| Q2 24 | $-17.6M | $-2.2M | ||
| Q1 24 | $-13.7M | $-886.0K |
毛利率DNTHSINT
| Q4 25 | — | 64.8% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 73.7% | ||
| Q2 24 | — | 73.9% | ||
| Q1 24 | — | 67.5% |
营业利润率DNTHSINT
| Q4 25 | -24486.3% | -799.3% | ||
| Q3 25 | -10173.7% | -1613.0% | ||
| Q2 25 | — | -1764.9% | ||
| Q1 25 | -2852.7% | -645.8% | ||
| Q4 24 | -2406.9% | -319.6% | ||
| Q3 24 | -1376.6% | -802.0% | ||
| Q2 24 | -1191.8% | -315.5% | ||
| Q1 24 | -2041.6% | -465.4% |
净利率DNTHSINT
| Q4 25 | -22687.3% | -763.8% | ||
| Q3 25 | -9284.1% | -1701.4% | ||
| Q2 25 | — | -1535.1% | ||
| Q1 25 | -2537.5% | -621.1% | ||
| Q4 24 | -2144.8% | -312.7% | ||
| Q3 24 | -1159.0% | -780.9% | ||
| Q2 24 | -945.1% | -256.6% | ||
| Q1 24 | -1573.0% | -129.0% |
每股收益（稀释后）DNTHSINT
| Q4 25 | $-1.53 | $-0.50 | ||
| Q3 25 | $-0.97 | $-3.46 | ||
| Q2 25 | — | $-0.91 | ||
| Q1 25 | $-0.82 | $-1.29 | ||
| Q4 24 | $-0.76 | $17.04 | ||
| Q3 24 | $-0.74 | $-6.96 | ||
| Q2 24 | $-0.51 | $-3.61 | ||
| Q1 24 | $-0.54 | $-21.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $404.3M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $493.4M | $2.9M |
| 总资产 | $530.9M | $9.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DNTHSINT
| Q4 25 | $404.3M | $4.1M | ||
| Q3 25 | $402.6M | $6.3M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | $263.2M | $6.5M | ||
| Q4 24 | $275.2M | $3.6M | ||
| Q3 24 | $281.1M | $4.8M | ||
| Q2 24 | $360.7M | $4.6M | ||
| Q1 24 | $377.0M | $5.8M |
股东权益DNTHSINT
| Q4 25 | $493.4M | $2.9M | ||
| Q3 25 | $546.5M | $4.1M | ||
| Q2 25 | — | $4.0M | ||
| Q1 25 | $328.6M | $6.1M | ||
| Q4 24 | $352.5M | $3.9M | ||
| Q3 24 | $337.9M | $5.6M | ||
| Q2 24 | $358.2M | $8.8M | ||
| Q1 24 | $372.7M | $9.9M |
总资产DNTHSINT
| Q4 25 | $530.9M | $9.5M | ||
| Q3 25 | $577.4M | $11.4M | ||
| Q2 25 | — | $9.2M | ||
| Q1 25 | $348.6M | $11.4M | ||
| Q4 24 | $374.0M | $9.4M | ||
| Q3 24 | $354.2M | $11.3M | ||
| Q2 24 | $369.0M | $15.3M | ||
| Q1 24 | $382.5M | $17.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.0M | $-2.3M |
| 自由现金流经营现金流 - 资本支出 | $-47.1M | $-2.4M |
| 自由现金流率自由现金流/营收 | -16591.9% | -822.8% |
| 资本支出强度资本支出/营收 | 48.6% | 14.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-132.8M | — |
8季度趋势，按日历期对齐
经营现金流DNTHSINT
| Q4 25 | $-47.0M | $-2.3M | ||
| Q3 25 | $-30.6M | $-2.5M | ||
| Q2 25 | — | $-2.4M | ||
| Q1 25 | $-27.6M | $-1.3M | ||
| Q4 24 | $-27.4M | $-1.1M | ||
| Q3 24 | $-21.3M | $-2.6M | ||
| Q2 24 | $-14.5M | $-2.2M | ||
| Q1 24 | $-14.9M | $-2.7M |
自由现金流DNTHSINT
| Q4 25 | $-47.1M | $-2.4M | ||
| Q3 25 | $-30.6M | $-2.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-27.7M | $-1.4M | ||
| Q4 24 | $-27.5M | $-1.3M | ||
| Q3 24 | $-21.3M | $-2.6M | ||
| Q2 24 | $-14.5M | $-2.6M | ||
| Q1 24 | $-15.0M | $-2.9M |
自由现金流率DNTHSINT
| Q4 25 | -16591.9% | -822.8% | ||
| Q3 25 | -7717.2% | -1250.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | -2377.8% | -368.6% | ||
| Q4 24 | -2072.0% | -234.3% | ||
| Q3 24 | -980.3% | -323.0% | ||
| Q2 24 | -780.7% | -299.7% | ||
| Q1 24 | -1713.2% | -423.1% |
资本支出强度DNTHSINT
| Q4 25 | 48.6% | 14.5% | ||
| Q3 25 | 1.3% | 40.4% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 2.1% | 16.0% | ||
| Q4 24 | 2.3% | 26.9% | ||
| Q3 24 | 1.2% | 1.4% | ||
| Q2 24 | 0.9% | 41.8% | ||
| Q1 24 | 3.7% | 25.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
